2-(2-Chloro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

(R)-(+)-SEGPHOS(regR)>99.0%(HPLC)200mg

(4S,5R)-3-((2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 97%, 5g

{1-[3-(trifluoromethyl)phenyl]cyclobutyl}methanamine, 97%, 500mg

(2E)-1-(2,4-dimethylphenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

N-[2-(ethylthio)ethyl]cyclohexanamine hydrochloride, 95.0%, 1g

4-(4-Fluorophenyl)butan-2-one, 97.0%, 250mg

TERT-BUTYL 7-OXO-5-OXA-2-AZASPIRO[3.4]OCTANE-2-CARBOXYLATE, 95.0%, 5g

(R)-tert-butyl 3-methyl-5-oxopiperidine-1-carboxylate, 95%, 500mg

(S)-1-(Pyridin-2-yl)ethanamine dihydrochloride, 95.0%, 250mg

1,4-Diazabicyclo [2.2.2] octane, 99.0%, 1kg

2-Bromo-1,5-dimethoxy-3-methylbenzene, 97%, 1g

2,3-Dimethoxybenzamide, 97.0%, 100g